Sonendo Inc
OTC:SONX
Relative Value
There is not enough data to reliably calculate the relative value of SONX.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SONX Competitors Multiples
Sonendo Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Sonendo Inc
OTC:SONX
|
106.8k USD | 0 | -0 | 0.3 | 0.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
193.4B USD | 4.3 | 29.5 | 16.9 | 23.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.4B USD | 17.4 | 61.4 | 46.6 | 57.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
142.2B USD | 5.6 | 43.5 | 22.1 | 26.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
119.2B USD | 3.4 | 25.8 | 14.1 | 20.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.8B USD | 5.3 | 36.8 | 21.6 | 29 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46B EUR | 2 | 21.7 | 12 | 16.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
49.4B USD | 11.4 | 46.5 | 33 | 36.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.8B USD | 8 | 45 | 24.7 | 27.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.2B USD | 2.2 | 27.2 | 10.6 | 17.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.9B USD | 6.8 | 24.9 | 17.6 | 19.5 |